Illumina
Focus: Illumina is a leader in genomic sequencing and molecular diagnostics, providing NGS platforms and genomic tools across oncology, rare disease, and infectious disease applications. The company operates as a diagnostics-focused business with a diversified clinical and research portfolio.
Profile data last refreshed 9h ago · AI intelligence enriched 3w ago
Open Jobs
170+98 this month
Hot — 178 jobs added in 30d
Net +98 (178 new, 80 removed). Aggressive expansion phase.
5 recent layoff filings (12 mo) — 16 affected
- 1/14/2026 — CA · 1 affected · Layoff Amendment
- 1/14/2026 — 5200 Illumina Way San Diego CA 92122, CA · 4 affected · Layoff Amendment
- 12/22/2025 — CA · 1 affected · Layoff Amendment
- +2 more
Source: state DOL filings via Big Local News
Should You Work at Illumina?
AI assessmentIllumina offers strong technical and commercial growth opportunities in genomics, but recent layoff patterns warrant caution about organizational stability and long-term role security.
Why Work Here
- Strong hiring momentum across Engineering (42 roles), Manufacturing (15), and Commercial (15) suggests active business expansion and product scaling opportunities
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
clinical whole genome sequencing
Rare DiseasesClinical Trials (1)
NCT03290469NICUSeq: A Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants
N/AHelp build intelligence for Illumina
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.